Credit Suisse First Boston

Total investments

45

Average round size

77M

Portfolio companies

39

Rounds per year

1.73

Lead investments

4

Follow on index

0.13

Exits

17

Stages of investment
Private Equity
Areas of investment
BiotechnologyInternetSoftwareInformation TechnologyHealth CareEnterprise SoftwareManufacturingPharmaceuticalTelecommunicationsService Industry

Summary

Credit Suisse First Boston is the famous Corporate Investor, which was founded in 1996. The venture was found in Europe in Switzerland. The main department of described Corporate Investor is located in the Zurich.

The typical case for the fund is to invest in rounds with 7-8 participants. Despite the Credit Suisse First Boston, startups are often financed by Novo Holdings, Mayfield Fund, HealthCap. The meaningful sponsors for the fund in investment in the same round are Wheatley Partners, New Enterprise Associates, Morgan Stanley Dean Witter. In the next rounds fund is usually obtained by Bay City Capital, Vulcan Capital, New Enterprise Associates.

Among the most popular portfolio startups of the fund, we may highlight RightNow Technologies, Salesforce, TradingEdge. Among the most successful fund investment fields, there are Optical Communication, Manufacturing. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low.

Deals in the range of 50 - 100 millions dollars are the general things for fund. The real fund results show that this Corporate Investor is 9 percentage points less often commits exit comparing to other companies. The typical startup value when the investment from Credit Suisse First Boston is 100-500 millions dollars. The important activity for fund was in 2000. Comparing to the other companies, this Credit Suisse First Boston performs on 12 percentage points more the average number of lead investments. The fund is generally included in 2-6 deals every year. The increased amount of exits for fund were in 2005.

We also calculated 50 valuable employees in our database.

Show more

Investments analytics

Analytics

Total investments
45
Lead investments
4
Exits
17
Rounds per year
1.73
Follow on index
0.13
Investments by industry
  • Internet (13)
  • Biotechnology (8)
  • Health Care (8)
  • Information Technology (8)
  • Enterprise Software (6)
  • Show 54 more
Investments by region
  • United States (40)
  • United Kingdom (2)
  • Canada (1)
Peak activity year
2000
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
22
Avg. valuation at time of investment
111M
Group Appearance index
0.98
Avg. company exit year
8
Avg. multiplicator
3.50
Strategy success index
0.60

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
RightNow Technologies 24 Jan 2001 Software, Information Technology, SaaS, Marketing, CRM, Customer Service Early Stage Venture 15M United States, Montana, Bozeman
Sunesis Pharmaceuticals 20 Dec 2002 Biotechnology, Health Care, Pharmaceutical Late Stage Venture 6M United States, California, South San Francisco

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.